GSDME-mediated pyroptosis contributes to chemotherapy-induced platelet hyperactivity and thrombotic potential

2.

Kedzierska

M

,

Czernek

U

,

Szydłowska-Pazera

K

, et al.

The changes of blood platelet activation in breast cancer patients before surgery, after surgery, and in various phases of the chemotherapy

.

Platelets

.

2013

;

24

(

6

):

462

-

468

.

3.

Hao

Z

,

Lv

H

,

Tan

R

,

Yang

X

,

Liu

Y

,

Xia

YL

.

A three-dimensional microfluidic device for monitoring cancer and chemotherapy-associated platelet activation

.

ACS Omega

.

2021

;

6

(

4

):

3164

-

3172

.

4.

Prandoni

P

,

Falanga

A

,

Piccioli

A

.

Cancer and venous thromboembolism

.

Lancet Oncol

.

2005

;

6

(

6

):

401

-

410

.

5.

Sousou

T

,

Khorana

AA

.

New insights into cancer-associated thrombosis

.

Arterioscler Thromb Vasc Biol

.

2009

;

29

(

3

):

316

-

320

.

6.

Heit

JA

,

Silverstein

MD

,

Mohr

DN

,

Petterson

TM

,

O'Fallon

WM

,

Melton

LJ

.

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

.

Arch Intern Med

.

2000

;

160

(

6

):

809

-

815

.

7.

Moore

RA

,

Adel

N

,

Riedel

E

, et al.

High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis

.

J Clin Oncol

.

2011

;

29

(

25

):

3466

-

3473

.

8.

Abdel-Razeq

H

,

Mansour

A

,

Abdulelah

H

, et al.

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look

.

Thromb J

.

2018

;

16

(

2

):

1

-

7

.

9.

Lee

YG

,

Lee

E

,

Kim

I

, et al.

Cisplatin-based chemotherapy is a strong risk factor for thromboembolic events in small-cell lung cancer

.

Cancer Res Treat

.

2015

;

47

(

4

):

670

-

675

.

10.

Haugnes

HS

,

Negaard

HF

,

Jensvoll

H

,

Wilsgaard

T

,

Tandstad

T

,

Solberg

A

.

Thromboembolic events during treatment with cisplatin-based chemotherapy in metastatic testicular germ-cell cancer 2000-2014: a population-based cohort study

.

Eur Urol Open Sci

.

2021

;

32

:

19

-

27

.

11.

Solari

L

,

Kronig

M

,

Ihorst

G

, et al.

High rates of thromboembolic events in patients with germ cell cancer undergoing cisplatin-based polychemotherapy

.

Urol Int

.

2016

;

96

(

4

):

399

-

405

.

12.

Hua

VM

,

Abeynaike

L

,

Glaros

E

, et al.

Necrotic platelets provide a procoagulant surface during thrombosis

.

Blood

.

2015

;

126

(

26

):

2852

-

2862

.

13.

Chen

X

,

Zhang

Y

,

Wang

Y

, et al.

PDK1 regulates platelet activation and arterial thrombosis

.

Blood

.

2013

;

121

(

18

):

3718

-

3726

.

14.

Leytin

V

.

Apoptosis in the anucleate platelet

.

Blood Rev

.

2012

;

26

(

2

):

51

-

63

.

15.

Togna

GI

,

Togna

AR

,

Franconi

M

,

Caprino

L

.

Cisplatin triggers platelet activation

.

Thromb Res

.

2000

;

99

(

5

):

503

-

509

.

16.

Leytin

V

,

Allen

DJ

,

Mutlu

A

, et al.

Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage

.

Br J Haematol

.

2008

;

142

(

3

):

494

-

497

.

17.

Wang

Y

,

Gao

W

,

Shi

X

, et al.

Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

.

Nature

.

2017

;

547

(

7661

):

99

-

103

.

18.

Wang

Y

,

Yin

B

,

Li

D

,

Wang

G

,

Han

X

,

Sun

X

.

GSDME mediates caspase-3-dependent pyroptosis in gastric cancer

.

Biochem Biophys Res Commun

.

2018

;

495

(

1

):

1418

-

1425

.

19.

Yu

P

,

Zhang

X

,

Liu

N

,

Tang

L

,

Peng

C

,

Chen

X

.

Pyroptosis: mechanisms and diseases

.

Signal Transduct Target Ther

.

2021

;

6

(

1

):

128

.

20.

Shi

J

,

Gao

W

,

Shao

F

.

Pyroptosis: gasdermin-mediated programmed necrotic cell Death

.

Trends Biochem Sci

.

2017

;

42

(

4

):

245

-

254

.

21.

Feng

S

,

Fox

D

,

Man

SM

.

Mechanisms of gasdermin family members in inflammasome signaling and cell death

.

J Mol Biol

.

2018

;

430

(

18 pt B

):

3068

-

3080

.

22.

Jiang

M

,

Qi

L

,

Li

L

, et al.

The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer

.

Cell Death Discov

.

2020

;

6

:

112

-

122

.

23.

Zhang

Y

,

Chen

X

,

Gueydan

C

, et al.

Plasma membrane changes during programmed cell deaths

.

Cell Res

.

2018

;

28

(

1

):

9

-

21

.

24.

Taabazuing

CY

,

Okondo

MC

,

Bachovchin

Daniel A

.

Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages

.

Cell Chem Biol

.

2017

;

24

(

4

):

507

-

514.e4

.

25.

Su

M

,

Chen

C

,

Li

S

, et al.

Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis

.

Nat Cardiovasc Res

.

2022

;

1

(

8

):

732

-

747

.

26.

Laer

LV

,

Huizing

EH

,

Verstreken

M

, et al.

Nonsyndromic hearing impairment is associated with a mutation in DFNA5

.

Nat Genet

.

1998

;

20

(

2

):

194

-

197

.

27.

Bender

M

,

Palankar

R

.

Platelet shape changes during thrombus formation: role of actin-based protrusions

.

Hämostaseologie

.

2021

;

41

(

1

):

14

-

21

.

28.

Ai

YL

,

Wang

WJ

,

Liu

FJ

, et al.

Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P

.

Cell Res

.

2023

;

33

(

12

):

904

-

922

.

29.

Zhang

W

,

Zhao

L

,

Liu

J

, et al.

Cisplatin induces platelet apoptosis through the ERK signaling pathway

.

Thromb Res

.

2012

;

130

(

1

):

81

-

91

.

30.

van der Meijden

PEJ

,

Heemskerk

JWM

.

Platelet biology and functions: new concepts and clinical perspectives

.

Nat Rev Cardiol

.

2019

;

16

(

3

):

166

-

179

.

31.

Heinjen

H

,

van der Sluijs

P.

.

Platelet secretory behaviour: as the granules …or not?

.

J Thromb Haemost

.

2015

;

13

(

12

):

2141

-

2151

.

32.

Langhorst

MF

,

Reuter

A

,

Jaeger

FA

, et al.

Trafficking of the microdomain scaffolding protein reggie-1/flotillin-2

.

Eur J Cell Biol

.

2008

;

87

(

4

):

211

-

226

.

33.

Salzer

U

,

Prohaska

R

.

Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts

.

Blood

.

2001

;

97

(

4

):

1141

-

1143

.

34.

Cronin-Fenton

DP

,

Sondergaard

F

,

Pedersen

LA

, et al.

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006

.

Br J Cancer

.

2010

;

103

(

7

):

947

-

953

.

35.

Khorana

AA

,

Dalal

M

,

Lin

J

, et al.

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States

.

Cancer

.

2013

;

119

(

3

):

648

-

655

.

36.

Zamorano

JL

,

Lancellotti

P

,

Rodriguez Munoz

D

, et al.

2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

.

Eur Heart J

.

2016

;

37

(

36

):

2768

-

2801

.

37.

Li

Y

,

Xin

G

,

Li

S

, et al.

PD-L1 regulates platelet activation and thrombosis via caspase-3/GSDME pathway

.

Front Pharmacol

.

2022

;

13

:

921414

.

38.

Kim

MS

,

Lebron

C

,

Nagpal

JK

, et al.

Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer

.

Biochem Biophys Res Commun

.

2008

;

370

(

1

):

38

-

43

.

39.

Lu

H

,

Zhang

S

,

Wu

J

, et al.

Molecular targeted therapies elicit concurrent apoptotic and GSDME-dependent pyroptotic tumor cell death

.

Clin Cancer Res

.

2018

;

24

(

23

):

6066

-

6077

.

40.

Fink

SL

,

Cookson

BT

.

Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells

.

Infect Immun

.

2005

;

73

(

4

):

1907

-

1916

.

41.

Jurk

K

,

Kehrel

BE

.

Platelets: physiology and biochemistry

.

Semin Thromb Hemost

.

2005

;

31

(

04

):

381

-

392

.

42.

Suzuki-Inoue

K

.

[Activation and inhibitory mechanisms of blood platelets]

.

Nihon Rinsho

.

2014

;

72

(

7

):

1212

-

1217

.

43.

Coppinger

JA

,

Cagney

G

,

Toomey

S

, et al.

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

.

Blood

.

2004

;

103

(

6

):

2096

-

2104

.

44.

Kahr

WHA

.

Granules and thrombus formation

.

Blood

.

2009

;

114

(

5

):

932

-

933

.

45.

Sehgal

S

,

Storrie

B

.

Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release

.

J Thromb Haemost

.

2007

;

5

(

10

):

2009

-

2016

.

46.

Polasek

J

.

Estrogens, platelets and lysosomes

.

J Thromb Haemost

.

2003

;

1

(

4

):

856

-

857

.

47.

Xu

X

,

Sun

B

.

Platelet granule secretion mechanisms: are they modified in sepsis?

.

Thromb Res

.

2015

;

136

(

5

):

845

-

850

.

48.

Tavernarakis

N

,

Driscoll

M

,

Kyrpides

NC

.

The SPFH domain: implicated in regulating targeted protein turnover in stomatins and other membrane-associated proteins

.

Trends Biochem Sci

.

1999

;

24

(

11

):

425

-

427

.

49.

Hiller

NL

,

Akompong

T

,

Morrow

JS

,

Holder

AA

,

Haldar

K

.

Identification of a stomatin orthologue in vacuoles induced in human erythrocytes by malaria parasites. A role for microbial raft proteins in apicomplexan vacuole biogenesis

.

J Biol Chem

.

2003

;

278

(

48

):

48413

-

48421

.

50.

Murphy

SC

,

Samuel

BU

,

Harrison

T

, et al.

Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection

.

Blood

.

2004

;

103

(

5

):

1920

-

1928

.

51.

Nagao

E

,

Seydel

KB

,

Dvorak

JA

.

Detergent-resistant erythrocyte membrane rafts are modified by a Plasmodium falciparum infection

.

Exp Parasitol

.

2002

;

102

(

1

):

57

-

59

.

52.

Sugawara

Y

,

Nishii

H

,

Takahashi

T

, et al.

The lipid raft proteins flotillins/reggies interact with Galphaq and are involved in Gq-mediated p38 mitogen-activated protein kinase activation through tyrosine kinase

.

Cell Signal

.

2007

;

19

(

6

):

1301

-

1308

.

53.

Browman

DT

,

Hoegg

MB

,

Robbins

SM

.

The SPFH domain-containing proteins: more than lipid raft markers

.

Trends Cell Biol

.

2007

;

17

(

8

):

394

-

402

.

54.

Bodin

S

,

Tronchere

H

,

Payrastre

B

.

Lipid rafts are critical membrane domains in blood platelet activation processes

.

Biochim Biophys Acta

.

2003

;

1610

(

2

):

247

-

257

.

55.

Pradhan

S

,

Vijayan

KV

.

Lipid rafts contribute to agonist-induced serine/threonine phosphatase activation and platelet aggregation

.

J Thromb Haemost

.

2013

;

11

(

8

):

1612

-

1615

.